Holen Sie sich die Stockscreener-App
1.58
1.28%
0.02
Imunon Inc Aktie (IMNN) Neueste Nachrichten
Imunon (IMNN) Q2 2026 Filing Snapshot: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Stock Move: Shares Move 1.25% Lower on the DayEarnings Revision Upgrade - vinanet.vn
Imunon (IMNN) General Counsel and Corp Sec Susan Eylward Sells 2,449 Shares - GuruFocus
Imunon (IMNN) pays executive chair with 7,147 shares - Stock Titan
Imunon (IMNN) CEO takes 6,615 shares instead of cash pay - Stock Titan
Imunon (IMNN) pays CMO with 3,516-share stock grant - Stock Titan
Imunon (IMNN) counsel gets stock in lieu of pay, then sells 2,449 shares - Stock Titan
Imunon General Counsel Susan Eylward disposes of 2,449 common shares worth $3,992.54 - Bitget
Imunon (IMNN) Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 4.43% BounceProduct Revenue Analysis - vinanet.vn
Imunon Inc. (IMNN) Advances 4.43% as Biotech Stock Tests Key Resistance at $1.73Fair Value Gap - dars.gov.et
Imunon Inc (NASDAQ: IMNN) Share Price, IMNN Stock News, IMNN Share Price & Updates - Kalkine
Armistice Capital (IMNN) discloses 9.99% Imunon stake via Master Fund - Stock Titan
IMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025 - kalkine.ca
Earnings call transcript: Imunon beats Q2 2026 EPS forecast as shares stay weak - Investing.com UK
Imunon (IMNN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Imunon Q2 2026 Loss Shrinks 42.6%: -$0.54/Share vs -$0.94 Expected - AlphaStreet
Imunon Q2 2026 Earnings Call Transcript - MarketBeat
Imunon Adopts New Equity-Based Executive Compensation Program - TipRanks
Imunon, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Imunon, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Form 8K Imunon Inc For: 11 August By Investing.com - Investing.com Australia
Q2 2026 Imunon Inc Earnings Call Transcript - GuruFocus
Imunon Inc (IMNN) Advances Phase 3 Trial Amidst Challenging Valu - GuruFocus
Imunon, Inc. 2Q 2026: Net loss $(2.83M), EPS $(0.54) — 10-Q Summary - TradingView
IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Imunon Q2 net loss widens slightly as R&D costs rise - tradingview.com
IMUNON reports $2.8 million Q2 loss as OVATION 3 enrollment advances - Quiver Quantitative
Imunon reports Q2 2026 net loss $2.8M; cash $6.9M, advances Phase 3 OVATION 3 - TradingView
BRIEF-Imunon Q2 EPS USD -0.54 - TradingView
IMNN Q2 2026 Earnings: EPS Loss of $0.54 Beats Estimates by 42.83%; Stock Rises 0.61Quarterly Earnings Report - vinanet.vn
IMNN Q1 2026 Earnings: Narrower Loss Beats Estimates as Clinical Pipeline AdvancesEarnings Cycle Outlook - vinanet.vn
Imunon Inc expected to post a loss of 93 cents a shareEarnings Preview - TradingView
Imunon Inc. (CBO0.SG) cash flow - Yahoo Finance UK
Imunon (IMNN.US) will release its earnings report on August 11. - Moomoo
Imunon (IMNN) General Counsel Susan Eylward Sells 2,541 Shares - GuruFocus
Imunon, Inc. (IMNN) director granted 6,934 shares in lieu of fees - stocktitan.net
Imunon (IMNN) director granted 6,934 shares of stock for board fees - Stock Titan
Imunon (IMNN) grants director 6,934 shares instead of cash board fees - Stock Titan
Imunon (NASDAQ: IMNN) awards director 6,180 shares for board fees - Stock Titan
Imunon, Inc. (IMNN) general counsel grants and sells 2,541 shares - stocktitan.net
Imunon, Inc. (IMNN) grants chair 6,358 shares instead of cash salary - Stock Titan
Imunon, Inc. (IMNN) CMO granted stock in lieu of cash pay - Stock Titan
Imunon, Inc. (IMNN) CEO awarded 5,010-share stock grant as compensation - Stock Titan
IMUNON to Hold Second Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, August 11, 2026 - The Manila Times
Imunon Inc. (IMNN) Q1 2026 Earnings: Narrower Net Loss Beats Expectations, Shares Edge HigherEarnings Deceleration Risk - vinanet.vn
Imunon (IMNN.US) will release its earnings report on August 4. - Moomoo
IMUNON reports faster-than-expected enrollment in ovarian cancer trial By Investing.com - Investing.com Nigeria
IMUNON Reports Faster-Than-Expected Enrollment in Phase 3 OVATION 3 Trial of IMNN-001 for Advanced Ovarian Cancer - Quiver Quantitative
IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer - GlobeNewswire
Imunon Q1 2026 Earnings: EPS Surprises to the Upside as Narrower Loss Beats EstimatesEarnings Per Share - vinanet.vn
IMNN|Imunon Inc|Price:1.514|Chg%:+0.004 - TradingKey
Imunon Inc (IMNN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Imunon Inc (IMNN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IMNN Q1 2026 Earnings: EPS Beat Narrows Loss Amid Ongoing Pipeline DevelopmentMargin Expansion Trends - vinanet.vn
Imunon Inc (IMNN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Imunon Inc (IMNN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Imunon Inc (IMNN) Cash Flow - TradingKey
IMNN|Imunon Inc|Price:1.510|Chg%:-0.150 - TradingKey
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):